Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
Author:
Publisher
Informa UK Limited
Subject
General Medicine
Reference16 articles.
1. Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
2. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
3. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
4. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
5. Beovu [Package Insert]. East Hanover, NJ: Novartis Inc; 2019.
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Brolucizumab effectiveness in pigment epithelium detachment due to exudative AMD in naïve treatment or non-responder patients;European Journal of Ophthalmology;2024-03-11
2. Age-Related Macular Degeneration and its Current Treatment Strategies: An Updated Review;Macular Diseases - An Update;2024-02-09
3. Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis;Clinical Ophthalmology;2023-09
4. Cytokine profiles in the aqueous humor following brolucizumab administration for exudative age-related macular degeneration;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-03-31
5. Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration;Clinical Ophthalmology;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3